The effects of stimulant dose and dosing strategy on treatment outcomes in attention-deficit/hyperactivity disorder in children and adolescents: a meta-analysis-Reference-Cited by-同舟云学术

The effects of stimulant dose and dosing strategy on treatment outcomes in attention-deficit/hyperactivity disorder in children and adolescents: a meta-analysis

Published:2022-01-14 Issue:3 Volume:27 Page:1562-1572
ISSN:1359-4184
Container-title:Molecular Psychiatry
language:en
Short-container-title:Mol Psychiatry

Author:

Farhat Luis C.^ORCID,Flores José M.,Behling Emily^ORCID,Avila-Quintero Victor J.^ORCID,Lombroso Adam,Cortese Samuele,Polanczyk Guilherme V.,Bloch Michael H.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology

Link

https://www.nature.com/articles/s41380-021-01391-9.pdf

Reference69 articles.

1. Cortese S. Pharmacologic treatment of attention deficit-hyperactivity disorder. N Engl J Med. 2020;383:1050–6.

2. National Institute for Health and Care Excellence. Attention deficit hyperactivity disorder: diagnosis and management 2018 [Available from: https://www.nice.org.uk/guidance/ng87].

3. Wolraich ML, Hagan JF Jr, Allan C, Chan E, Davison D, Earls M, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019;144:e20192528.

4. Pliszka S. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46:894–921.

5. Canadian ADHD Resource Alliance (CADDRA). Canadian ADHD Practice Guidelines, Fourth Edition, Toronto, 2018.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Incident Psychosis and Mania With Prescription Amphetamines;American Journal of Psychiatry;2024-09-12

2. SERDEXMETHYLPHENIDATE;Prescriber's Guide – Children and Adolescents;2024-05-02

3. METHYLPHENIDATE (d,l);Prescriber's Guide – Children and Adolescents;2024-05-02

4. METHYLPHENIDATE (d);Prescriber's Guide – Children and Adolescents;2024-05-02

5. LISDEXAMFETAMINE;Prescriber's Guide – Children and Adolescents;2024-05-02